Theravance Biopharma (TBPH) Receivables (2013 - 2019)
Theravance Biopharma's Receivables was $16.75 million in Q3 2019, up 141.6% from $6.93 million a year earlier but down 16.8% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Receivables (2013 - 2019) Analysis & Trends
At the end of FY2018, Receivables at Theravance Biopharma came in at $10.67 million, up 14.0% from FY2017.
- Receivables shows a five-year compound annual growth rate of 56.6% (FY2013 to FY2018).
- In earlier years, Receivables was $9.36 million in FY2017 (-3.7%), $9.72 million in FY2016 (-73.8%), $37.15 million in FY2015 and $2.13 million in FY2014 (+87.9%).
- Quarterly Receivables has moved between $2.13 million (Q4 2014) and $39.06 million (Q1 2016) over five years.
- Compared with a year earlier, Receivables has increased for four straight quarters, with growth averaging 38.6% over the last eight quarters.
- The best year-over-year quarter for Receivables over five years was Q2 2019 (growth of 175.8%); the worst was Q2 2017 (a decline of 82.0%).
- Per Business Quant data, TBPH's Receivables in the three quarters before Q3 2019 was $20.13 million (Q2 2019), $7.94 million (Q1 2019) and $10.67 million (Q4 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 16.75 Mn |
| Jun 30, 2019 | 20.13 Mn |
| Mar 31, 2019 | 7.94 Mn |
| Dec 31, 2018 | 10.67 Mn |
| Sep 30, 2018 | 6.93 Mn |
| Jun 30, 2018 | 7.30 Mn |
| Mar 31, 2018 | 4.82 Mn |
| Dec 31, 2017 | 9.36 Mn |
| Sep 30, 2017 | 13.12 Mn |
| Jun 30, 2017 | 6.66 Mn |
| Mar 31, 2017 | 8.87 Mn |
| Dec 31, 2016 | 9.72 Mn |
| Sep 30, 2016 | 23.59 Mn |
| Jun 30, 2016 | 36.94 Mn |
| Mar 31, 2016 | 39.06 Mn |
| Dec 31, 2015 | 37.15 Mn |
| Sep 30, 2015 | 20.42 Mn |
| Jun 30, 2015 | 26.29 Mn |
| Mar 31, 2015 | 20.23 Mn |
| Dec 31, 2014 | 2.13 Mn |
API Access
Theravance Biopharma Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();